Squarepoint
ACLX

Squarepoint’s Arcellx ACLX Stock Holding History

Squarepoint’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,300
Closed -$807K – 4431
2025
Q1 		$807K Buy
+12,300
New +$833K ﹤0.01% 2856

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Squarepoint's ACLX Position: Q1 2026 in Review

Squarepoint reduced its Arcellx (ACLX) stake by 46% in Q1 2026, selling an estimated $2.01M and leaving 27,145 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1860.

Squarepoint first reported a position in ACLX in Q1 2022 and has held it in 11 quarters since. The position peaked at $8.42M in Q1 2024. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Squarepoint held 27,145 shares of Arcellx worth $3.12M as of Q1 2026.
  • Squarepoint sold 22,730 Arcellx shares in Q1 2026, an estimated $2.01M.
  • Arcellx made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #1860 holding.
  • Squarepoint first reported a position in Arcellx in Q1 2022 and has held it in 11 quarters since.
  • Squarepoint's Arcellx position peaked at $8.42M in Q1 2024.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.